pseudoephedrine hydrochloride 30 mg tablets + Placebo tablets
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Nasal Congestion Associated With the Common Cold
Conditions
Nasal Congestion Associated With the Common Cold
Trial Timeline
Nov 1, 2012 → Apr 1, 2016
NCT ID
NCT01744106About pseudoephedrine hydrochloride 30 mg tablets + Placebo tablets
pseudoephedrine hydrochloride 30 mg tablets + Placebo tablets is a phase 3 stage product being developed by Pfizer for Nasal Congestion Associated With the Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT01744106. Target conditions include Nasal Congestion Associated With the Common Cold.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01744106 | Phase 3 | Completed |
Competing Products
20 competing products in Nasal Congestion Associated With the Common Cold